• Register
  • Login
  • Subscribe
  • Contact Us

The Supply of the Drug "Budesonide+Glycoppyronia Bromide+Formoterol" to Provide Patients with the Provision of a Patient Entitled to Preferential Drug Provision to Solve Medical to ...

RussianTenders notice for The Supply of the Drug "Budesonide+Glycoppyronia Bromide+Formoterol" to Provide Patients with the Provision of a Patient Entitled to Preferential Drug Provision to Solve Medical to .... The reference ID of the tender is 118331208 and it is closing on 12 May 2025.

Tender Details

  • Country: Russia
  • Summary: The Supply of the Drug "Budesonide+Glycoppyronia Bromide+Formoterol" to Provide Patients with the Provision of a Patient Entitled to Preferential Drug Provision to Solve Medical to ...
  • RUT Ref No: 118331208
  • Deadline: 12 May 2025
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: RUB 111412.08
  • Notice Type: Tender
  • Document Ref. No.: 32514794930
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • Lot name:- supply of the drug "Budesonide+glycopphyrony bromide+formoterol" to provide patients with the patient who are entitled to preferential drug provision to decision the medical commission, in accordance with the Decree of the Government of the Russian Federation from the Russian Federation07/30/1994 No. 890 "On state support for the development of the medical industry and improving the provision of the population and healthcare institutions with medicines and medical devices" (Protocol 73).
    Combination of anti -inflammatoryPreparatory border
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

The Supply of the Drug "Budesonide+Glycoppyronia Bromide+Formoterol" to Provide Patients with the Provision of a Patient Entitled to Preferential Drug Provision to Solve Medical to ... - Russian Tender

The STATE AUTONOMOUS INSTITUTION OF HEALTH REPUBLICAN CLINICAL HOSPITAL NAMED AFTER N.A. SEMASHKO OF THE MINISTRY OF HEALTH OF THE REPUBLIC OF BURYATIA, a Government sector organization in Russia, has announced a new tender for The Supply of the Drug "Budesonide+Glycoppyronia Bromide+Formoterol" to Provide Patients with the Provision of a Patient Entitled to Preferential Drug Provision to Solve Medical to .... This tender is published on RussianTenders under RUT Ref No: 118331208 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-12.

The estimated tender value is RUB 111412.08, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

RussianTenders Features

RussianTenders Features

Fresh and verified Tenders from Russian. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting RussianTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Russian in your email inbox.

  Chat with us